{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:48:42Z","timestamp":1790948922041,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Sciences Centre","award":["N N405 668440"],"award-info":[{"award-number":["N N405 668440"]}]},{"name":"Bavarian Polymer Institute"},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB840"],"award-info":[{"award-number":["SFB840"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejps.2018.10.018","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T16:11:16Z","timestamp":1539792676000},"page":"92-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Comparison of the in vitro cytotoxicity among phospholipid-based parenteral drug delivery systems: Emulsions, liposomes and aqueous lecithin dispersions (WLDs)"],"prefix":"10.1016","volume":"127","author":[{"given":"Marcin","family":"P\u0142aczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"W\u0105tr\u00f3bska-\u015awietlikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Stefanowicz-Hajduk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga Renata","family":"Ochocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Sznitowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.10.018_bb0005","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1002\/jps.22111","article-title":"The effect of novel surfactants and solutol HS15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer","volume":"99","author":"Alani","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.018_bb0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tiv.2014.11.009","article-title":"Liposomes and MTT cell viability assay: an incompatible affair","volume":"29","author":"Angius","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2018.10.018_bb0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijpharm.2013.04.068","article-title":"Efficacy of edelfosine lipid nanoparticles in breast cancer cells","volume":"454","author":"Aznar","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0020","series-title":"Methods in Membrane Biology","first-page":"1","article-title":"Preparation and use of liposomes as models of biological membranes","author":"Bangham","year":"1974"},{"key":"10.1016\/j.ejps.2018.10.018_bb0025","first-page":"105","article-title":"Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals","volume":"3","author":"Barar","year":"2013","journal-title":"Bioimpacts"},{"key":"10.1016\/j.ejps.2018.10.018_bb0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jps.2600821102","article-title":"Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization","volume":"82","author":"Benita","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.018_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2018.10.018_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14712\/18059694.2015.48","article-title":"Antiproliferative effects of selected chemotherapeutics in human ovarian cancer cell line A2780","volume":"55","author":"Caltov\u00e1","year":"2012","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.ejps.2018.10.018_bb0045","first-page":"49","article-title":"Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy","volume":"7","author":"Chang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2018.10.018_bb0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/js980293i","article-title":"Effect of surface charge on the stability of oil\/water emulsions during steam sterilization","volume":"88","author":"Chansiri","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.018_bb0055","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"3583","article-title":"Surfactants in pharmaceutical products and systems","author":"Corrigan","year":"2007"},{"key":"10.1016\/j.ejps.2018.10.018_bb0060","article-title":"Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence system","volume":"66","author":"Erskine","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejps.2018.10.018_bb0065","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"258","article-title":"Biotechnology and biological preparations","author":"Evens","year":"2007"},{"key":"10.1016\/j.ejps.2018.10.018_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0939-6411(98)00037-X","article-title":"Increasing drug solubility by means of bile salt\u2013phosphatidylcholine-based mixed micelles","volume":"43","author":"Hammad","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0075","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1208\/s12249-010-9526-5","article-title":"Injectable lipid emulsions \u2013 advancements, opportunities and challenges","volume":"11","author":"Hippalgaonkar","year":"2010","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ejps.2018.10.018_bb0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2174\/0929867033457412","article-title":"Cationic lipid vectors for plasmid DNA delivery","volume":"10","author":"Hirko","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2018.10.018_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0939-6411(02)00057-7","article-title":"Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability","volume":"54","author":"Jumaa","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.colsurfb.2007.09.027","article-title":"Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems","volume":"62","author":"Kawaguchi","year":"2008","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2018.10.018_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/bios5020199","article-title":"Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time","volume":"5","author":"Kho","year":"2015","journal-title":"Biosensors"},{"key":"10.1016\/j.ejps.2018.10.018_bb0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.biomaterials.2012.09.067","article-title":"Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis","volume":"34","author":"Kong","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.10.018_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.colsurfb.2012.06.002","article-title":"Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia","volume":"101","author":"Kuo","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2018.10.018_bb0110","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.tiv.2012.08.019","article-title":"A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effects","volume":"27","author":"Kustermann","year":"2013","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2018.10.018_bb0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3892\/ijo.2014.2246","article-title":"Cholesterol induces autophagic and apoptotic death in gastric carcinoma cells","volume":"44","author":"Lim","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2018.10.018_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-anchem-062011-143134","article-title":"Assessing nanoparticle toxicity","volume":"5","author":"Love","year":"2012","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.ejps.2018.10.018_bb0125","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1038\/srep05005","article-title":"Cholesterol level affects surface charge of lipid membranes in saline solution","volume":"4","author":"Magarkar","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2018.10.018_bb0130","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.tiv.2014.12.021","article-title":"Biodegradable nanoparticles designed for drug delivery: the number of nanoparticles impacts on cytotoxicity","volume":"29","author":"Mendes","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2018.10.018_bb0135","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1345\/aph.1M626","article-title":"State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications","volume":"44","author":"Mirtallo","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2018.10.018_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2004.07.010","article-title":"Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability","volume":"285","author":"Mohammed","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejps.2018.10.018_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future","volume":"47","author":"M\u00fcller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.10.018_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2010.02.014","article-title":"A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung","volume":"75","author":"Nassimi","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.colsurfb.2004.08.017","article-title":"Properties of various phosphatidylcholines as emulsifiers or dispersing agents in microparticle preparations for drug carriers","volume":"39","author":"Nii","year":"2004","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2018.10.018_bb0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/10611860310001636908","article-title":"Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells","volume":"11","author":"Omidi","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2018.10.018_bb0170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/10611860500418881","article-title":"Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type","volume":"13","author":"Omidi","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2018.10.018_bb0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/15376510801891286","article-title":"Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial A549 cells","volume":"18","author":"Omidi","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ejps.2018.10.018_bb0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jim.2014.01.012","article-title":"An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells","volume":"405","author":"Peper","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejps.2018.10.018_bb0185","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.3390\/ijms140611767","article-title":"Phospholipids at the interface: current trends and challenges","volume":"14","author":"Pichot","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2018.10.018_bb0190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2010.05.025","article-title":"Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine","volume":"395","author":"Rupp","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-62703-538-5_17","article-title":"Use of the xCELLigence system for real-time analysis of changes in cellular motility and adhesion in physiological conditions","volume":"1046","author":"Scrace","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejps.2018.10.018_bb0200","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.bmcl.2013.05.103","article-title":"Synthesis and characterization of a pH-sensitive conjugate of isoniazid with Fe3O4@SiO2 magnetic nanoparticles","volume":"23","author":"Sedlak","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2018.10.018_bb0205","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejpb.2004.03.026","article-title":"Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line","volume":"58","author":"Serpe","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.scitotenv.2012.06.018","article-title":"In vitro biocompatibility of solid lipid nanoparticles","volume":"432","author":"Silva","year":"2012","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ejps.2018.10.018_bb0220","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"3334","article-title":"Solubilizing excipients in pharmaceutical formulations","author":"Strickley","year":"2007"},{"key":"10.1016\/j.ejps.2018.10.018_bb0225","series-title":"Pharmaceutical Dosage Forms: Parenteral Medications","first-page":"134","article-title":"Drug solubility and solubilization","author":"Su","year":"2010"},{"key":"10.1016\/j.ejps.2018.10.018_bb0230","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-5173(02)00395-2","article-title":"Solubilizing potential of submicron emulsions and aqueous dispersions of lecithin","volume":"246","author":"Sznitowska","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.018_bb0235","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/02652040802586068","article-title":"Preliminary in vivo studies of a new lecithin-based formulation of paclitaxel","volume":"26","author":"Sznitowska","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2018.10.018_bb0240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bios.2012.03.024","article-title":"Real time monitoring of the cell viability during treatment with tumor-targeted toxins and saponins using impedance measurement","volume":"35","author":"Thakur","year":"2012","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ejps.2018.10.018_bb0245","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejps.2012.07.005","article-title":"Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer","volume":"47","author":"Ujhelyi","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.018_bb0250","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.2147\/IJN.S63433","article-title":"Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery","volume":"9","author":"Unterweger","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2018.10.018_bb0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dental.2009.08.007","article-title":"Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts","volume":"26","author":"Urcan","year":"2010","journal-title":"Dent. Mater."},{"key":"10.1016\/j.ejps.2018.10.018_bb0260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.ejps.2018.10.018_bb0265","first-page":"121","article-title":"The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques","volume":"30","author":"Vistejnova","year":"2009","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.ejps.2018.10.018_bb0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2007.07.012","article-title":"Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells","volume":"348","author":"Yuan","year":"2008","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:47:18Z","timestamp":1760528838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718304652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":53,"alternative-id":["S0928098718304652"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.018","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the in vitro cytotoxicity among phospholipid-based parenteral drug delivery systems: Emulsions, liposomes and aqueous lecithin dispersions (WLDs)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}